Study to Evaluate SID 530 Compared to Taxotere
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Non-Small Cell Lung Cancer
Interventions: DRUG: SID530, Taxotere
Sponsor: SK Chemicals Co., Ltd.